학술논문
Relevance of the 2022 American Academy of Pediatrics Hyperbilirubinemia Guidelines for an LMIC.
Document Type
Article
Source
Subject
*NEWBORN screening
*MIDDLE-income countries
*HEPATIC encephalopathy
*HYPERBILIRUBINEMIA
*PHOTOTHERAPY
*MEDICAL protocols
*ERYTHROBLASTOSIS fetalis
*LOW-income countries
*BILIRUBIN
*DISEASE risk factors
*
*
*
*
*
*
*
*
*
Language
ISSN
0031-4005
Abstract
The authors share insights on the relevance of the 2022 American Academy of Pediatrics' neonatal hyperbilirubinemia guidelines for low- and middle-income countries (LMIC). They suggest screening of neonates in high-risk populations to improve outcome of hyperbilirubinemia in newborns with glucose-6-phosphate dehydrogenase deficiency. They point out the lack of affordable Rh immunoglobulin, suboptimal continual care of newborns, and lack of maternal education in LMICs.